Stephanie Feldman

1.9k total citations
48 papers, 1.2k citations indexed

About

Stephanie Feldman is a scholar working on Psychiatry and Mental health, Clinical Psychology and Physiology. According to data from OpenAlex, Stephanie Feldman has authored 48 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Psychiatry and Mental health, 9 papers in Clinical Psychology and 8 papers in Physiology. Recurrent topics in Stephanie Feldman's work include Schizophrenia research and treatment (25 papers), Bipolar Disorder and Treatment (7 papers) and Smoking Behavior and Cessation (5 papers). Stephanie Feldman is often cited by papers focused on Schizophrenia research and treatment (25 papers), Bipolar Disorder and Treatment (7 papers) and Smoking Behavior and Cessation (5 papers). Stephanie Feldman collaborates with scholars based in United States, South Korea and Egypt. Stephanie Feldman's co-authors include Deanna L. Kelly, Robert P. McMahon, Robert R. Conley, Heidi J. Wehring, Robert W. Buchanan, M. Patricia Ball, James M. Gold, Raymond C. Love, Dwight Dickinson and Charles M. Richardson and has published in prestigious journals such as New England Journal of Medicine, American Journal of Psychiatry and The FASEB Journal.

In The Last Decade

Stephanie Feldman

47 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stephanie Feldman United States 24 585 213 209 209 178 48 1.2k
Jun Ishigooka Japan 24 757 1.3× 96 0.5× 241 1.2× 291 1.4× 167 0.9× 123 1.6k
Yuya Mizuno Japan 18 911 1.6× 257 1.2× 196 0.9× 192 0.9× 353 2.0× 35 1.7k
Heidi J. Wehring United States 21 484 0.8× 217 1.0× 126 0.6× 105 0.5× 121 0.7× 49 1.2k
Vladimir Lerner Israel 23 658 1.1× 163 0.8× 171 0.8× 179 0.9× 214 1.2× 95 1.6k
Spyridon Siafis Germany 22 985 1.7× 124 0.6× 149 0.7× 250 1.2× 258 1.4× 79 1.6k
Thomas J. Arndt United States 8 760 1.3× 105 0.5× 131 0.6× 171 0.8× 147 0.8× 8 1.1k
Franziska Schmid Germany 11 1.4k 2.4× 232 1.1× 144 0.7× 255 1.2× 271 1.5× 23 1.8k
Lotfi Gaha Tunisia 18 492 0.8× 121 0.6× 180 0.9× 105 0.5× 200 1.1× 111 1.5k
Atheeshaan Arumuham United Kingdom 8 517 0.9× 177 0.8× 117 0.6× 87 0.4× 110 0.6× 19 907
Philipp Rothe Germany 10 1.1k 1.8× 119 0.6× 127 0.6× 242 1.2× 234 1.3× 17 1.4k

Countries citing papers authored by Stephanie Feldman

Since Specialization
Citations

This map shows the geographic impact of Stephanie Feldman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephanie Feldman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephanie Feldman more than expected).

Fields of papers citing papers by Stephanie Feldman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephanie Feldman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephanie Feldman. The network helps show where Stephanie Feldman may publish in the future.

Co-authorship network of co-authors of Stephanie Feldman

This figure shows the co-authorship network connecting the top 25 collaborators of Stephanie Feldman. A scholar is included among the top collaborators of Stephanie Feldman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephanie Feldman. Stephanie Feldman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Feldman, Stephanie, Dipti Gupta, Babak B. Navi, et al.. (2023). Tumor Genomic Profile Is Associated With Arterial Thromboembolism Risk in Patients With Solid Cancer. JACC CardioOncology. 5(2). 246–255. 13 indexed citations
2.
Kelly, Deanna L., Stephanie Feldman, Sarah M. Clark, et al.. (2018). Increased circulating regulatory T cells in medicated people with schizophrenia. Psychiatry Research. 269. 517–523. 36 indexed citations
3.
Wehring, Heidi J., Joseph P. McEvoy, Gopal Vyas, et al.. (2017). Adjunctive Minocycline in Clozapine-Treated Patients with Schizophrenia: Analyzing the Effects of Minocycline on Clozapine Plasma Levels. Psychiatric Quarterly. 89(1). 73–80. 16 indexed citations
4.
Vyas, Gopal, Ann Hackman, Charles M. Richardson, et al.. (2017). Clozapine in Reducing Aggression and Violence in Forensic Populations. Psychiatric Quarterly. 89(1). 157–168. 26 indexed citations
5.
Sullivan, Kelli M., Fang Liu, Bethany A. DiPaula, et al.. (2016). Blood Pressure and Heart Rate Changes During Clozapine Treatment. Psychiatric Quarterly. 88(3). 545–552. 7 indexed citations
6.
Jackson, Jessica, William W. Eaton, Nicola G. Cascella, et al.. (2014). Gluten sensitivity and relationship to psychiatric symptoms in people with schizophrenia. Schizophrenia Research. 159(2-3). 539–542. 25 indexed citations
7.
Fischer, Bernard A., Robert P. McMahon, Deanna L. Kelly, et al.. (2014). Risk-taking in schizophrenia and controls with and without cannabis dependence. Schizophrenia Research. 161(2-3). 471–477. 24 indexed citations
8.
Weiner, Elaine, Robert R. Conley, M. Patricia Ball, et al.. (2010). Adjunctive Risperidone for Partially Responsive People with Schizophrenia Treated with Clozapine. Neuropsychopharmacology. 35(11). 2274–2283. 38 indexed citations
9.
Kelly, Deanna L., Suzanne Hoi Shan Lo, Katherine Wright, et al.. (2010). Perception of Smoking Risks and Motivation to Quit Among Nontreatment-Seeking Smokers With and Without Schizophrenia. Schizophrenia Bulletin. 38(3). 543–551. 36 indexed citations
10.
Kelly, Deanna L., et al.. (2009). Nonresponse to clozapine and premorbid functioning in treatment refractory schizophrenia. Comprehensive Psychiatry. 51(3). 298–302. 10 indexed citations
11.
Kelly, Deanna L., Robert P. McMahon, Heidi J. Wehring, et al.. (2009). Cigarette Smoking and Mortality Risk in People With Schizophrenia. Schizophrenia Bulletin. 37(4). 832–838. 124 indexed citations
12.
Kelly, Deanna L., Robert W. Buchanan, Douglas L. Boggs, et al.. (2009). A Randomized Double-Blind Trial of Atomoxetine for Cognitive Impairments in 32 People With Schizophrenia. The Journal of Clinical Psychiatry. 70(4). 518–525. 29 indexed citations
13.
Kelly, Deanna L., Heidi J. Wehring, Jared Linthicum, et al.. (2008). Cardiac-related findings at autopsy in people with severe mental illness treated with clozapine or risperidone. Schizophrenia Research. 107(2-3). 134–138. 24 indexed citations
14.
Conley, Robert R., Douglas L. Boggs, Deanna L. Kelly, et al.. (2008). The Effects of Galantamine on Psychopathology in Chronic Stable Schizophrenia. Clinical Neuropharmacology. 32(2). 69–74. 24 indexed citations
15.
Buchanan, Robert W., Robert R. Conley, Dwight Dickinson, et al.. (2007). Galantamine for the Treatment of Cognitive Impairments in People With Schizophrenia. American Journal of Psychiatry. 165(1). 82–89. 134 indexed citations
16.
Kelly, Deanna L., Robert R. Conley, Stephanie Feldman, et al.. (2006). Adjunct Divalproex or Lithium to Clozapine in Treatment-Resistant Schizophrenia. Psychiatric Quarterly. 77(1). 81–95. 55 indexed citations
17.
Conley, Robert R., Joo-Cheol Shim, Deanna L. Kelly, et al.. (2005). Cardiovascular disease in relation to weight in deceased persons with schizophrenia. Comprehensive Psychiatry. 46(6). 460–467. 11 indexed citations
18.
Kelly, Deanna L., Joo-Cheol Shim, Stephanie Feldman, Yang Yu, & Robert R. Conley. (2004). Lifetime psychiatric symptoms in persons with schizophrenia who died by suicide compared to other means of death. Journal of Psychiatric Research. 38(5). 531–536. 50 indexed citations
19.
Ruskin, Paul E., et al.. (1994). Continuous vs. Targeted Medication in Older Schizophrenic Outpatients. American Journal of Geriatric Psychiatry. 2(2). 134–143. 3 indexed citations
20.
Lehmann, H. E., et al.. (1988). An 11‐year follow‐up study of 110 depressed patients. Acta Psychiatrica Scandinavica. 78(1). 57–65. 59 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jun Ishigooka Breakdown of academic impact, for papers by Yuya Mizuno Breakdown of academic impact, for papers by Heidi J. Wehring Breakdown of academic impact, for papers by Vladimir Lerner Breakdown of academic impact, for papers by Spyridon Siafis Breakdown of academic impact, for papers by Thomas J. Arndt Breakdown of academic impact, for papers by Franziska Schmid Breakdown of academic impact, for papers by Lotfi Gaha Breakdown of academic impact, for papers by Atheeshaan Arumuham Breakdown of academic impact, for papers by Philipp Rothe
Rankless by CCL
2026